SUPN PEER ANALYSIS

Supernus Pharmaceuticals Inc — metric-by-metric comparison with peers and the industry median

SUPNSupernus Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

SUPNIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	SUPN	ROVI	BHC	ECILC	GENIL	HLN	Ind. Median
P/E	—	22.08●	—	—	46.82	31.28	21.37
P/B	2.57	4.32	-0.88●	0.80	3.47	1.98	1.82
EV/EBITDA	46.90	14.64	4.05●	33.84	14.07	19.15	12.26
P/S	3.57	3.93	0.21●	5.03	1.86	3.94	2.09

Financial Health
Metric	SUPN	ROVI	BHC	ECILC	GENIL	HLN	Ind. Median
Current Ratio	1.96	3.66●	1.32	1.73	1.33	0.92	2.22
Debt/Equity	3.8%	17.0%	-1,010.0%●	5.9%	41.0%	52.3%	46.3%
NetDebt/EBITDA	-6.64●	0.09	3.71	-0.10	1.10	3.50	1.24

Profitability
Metric	SUPN	ROVI	BHC	ECILC	GENIL	HLN	Ind. Median
Net Margin	-3.7%	17.8%●	-13.5%	-3.6%	4.0%	12.6%	4.0%
ROE	-2.8%	20.9%●	—	-0.6%	8.7%	6.3%	6.4%
ROA	-2.0%	15.1%●	-4.7%	-0.5%	4.8%	3.2%	3.4%
EBITDA Margin	6.7%	27.0%	60.0%●	14.8%	14.3%	25.2%	18.2%

Growth + Dividend
Metric	SUPN	ROVI	BHC	ECILC	GENIL	HLN	Ind. Median
Rev. Growth	16.3%	-3.4%	-9.9%	-2.3%	16.3%●	-26.7%	7.5%
NI Growth	—	-5.9%	—	—	146.6%●	-14.2%	5.0%
Div. Yield	—	1.6%	0.0%	2.6%●	0.0%	2.0%	2.0%
Payout	—	36.3%	0.0%	-365.1%	0.0%	40.0%	0.8%

Valuation
Metric	SUPN	BCRX	PBH	AMLX	ANIP	HROW	Ind. Median
P/E	—	—	12.38●	—	20.67	—	21.37
P/B	2.57	-4.30●	1.25	7.39	3.30	55.43	1.82
EV/EBITDA	46.90	—	10.08	—	7.97●	57.12	12.26
P/S	3.57	2.69	2.16	—	2.01●	5.92	2.09

Financial Health
Metric	SUPN	BCRX	PBH	AMLX	ANIP	HROW	Ind. Median
Current Ratio	1.96	1.91	3.57	17.85●	3.12	2.48	2.22
Debt/Equity	3.8%	-154.9%●	55.4%	2.1%	58.3%	1,047.4%	46.3%
NetDebt/EBITDA	-6.64●	-1.66	2.96	1.86	0.07	6.55	1.24

Profitability
Metric	SUPN	BCRX	PBH	AMLX	ANIP	HROW	Ind. Median
Net Margin	-3.7%	-51.7%	17.5%●	—	9.7%	-5.6%	4.0%
ROE	-2.8%	—	10.2%	-63.3%	17.8%●	-35.1%	6.4%
ROA	-2.0%	-96.9%	5.5%	-58.5%	6.6%●	-3.8%	3.4%
EBITDA Margin	6.7%	-42.1%	30.4%●	—	25.4%	11.7%	18.2%

Growth + Dividend
Metric	SUPN	BCRX	PBH	AMLX	ANIP	HROW	Ind. Median
Rev. Growth	16.3%	75.9%●	-4.3%	—	37.0%	26.2%	7.5%
NI Growth	—	—	-11.3%	—	—	—	5.0%
Div. Yield	—	—	—	—	0.0%	—	2.0%
Payout	—	—	—	—	0.8%	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on SUPN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.